Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Other financing activities (2019 - 2025)

Benitec Biopharma has reported Other financing activities over the past 7 years, most recently at $72000.0 for Q2 2025.

  • Quarterly results put Other financing activities at $72000.0 for Q2 2025, down 97.54% from a year ago — trailing twelve months through Jun 2025 was $2.3 million (down 60.64% YoY), and the annual figure for FY2025 was $2.3 million, down 60.64%.
  • Other financing activities reached $72000.0 in Q2 2025 per BNTC's latest filing, down from $2.2 million in the prior quarter.
  • Across five years, Other financing activities topped out at $3.0 million in Q3 2023 and bottomed at $2000.0 in Q4 2024.
  • Median Other financing activities over the past 5 years was $1.9 million (2022), compared with a mean of $1.7 million.
  • The largest annual shift saw Other financing activities skyrocketed 58.59% in 2023 before it crashed 97.54% in 2025.
  • Over 5 years, Other financing activities stood at $1.6 million in 2021, then grew by 17.92% to $1.9 million in 2022, then surged by 58.59% to $3.0 million in 2023, then crashed by 99.93% to $2000.0 in 2024, then skyrocketed by 3500.0% to $72000.0 in 2025.
  • Business Quant data shows Other financing activities for BNTC at $72000.0 in Q2 2025, $2.2 million in Q1 2025, and $2000.0 in Q4 2024.